Pegylated-Interferon Induced Severe Bone Marrow Hypoplasia in a Patient with Multiple Myeloma Receiving Thalidomide

American Journal of Hematology

Volumn 74, Issue 4, 2003, Pages 290-291

  Gómez Rangel, J David ^a   Ruiz Delgado, Guillermo J ^b   Ruiz Argüelles, Guillermo J ^a  

^a Ctro Hematol Med Int de Puebla   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; PEGINTERFERON; THALIDOMIDE; VINCRISTINE;

ADULT; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW BIOPSY; BONE MARROW HYPOPLASIA; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LETTER; LOW BACK PAIN; LUMBAR VERTEBRA; MULTIPLE MYELOMA; OSTEOLYSIS; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; BONE MARROW DISEASES; DRUG INTERACTIONS; FEMALE; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MIDDLE AGED; MULTIPLE MYELOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYETHYLENE GLYCOLS; THALIDOMIDE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0344875632     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10435     Document Type: Letter

References (5)

1. Bukowski RN, Tendler C, Cutler D, Rose E, Laughlin MM, Statkevich R. Treating cancer with PEG Intron. Pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulation. Cancer 2002;95:389-396.
2. Kyle RA. Management of patients with multiple myeloma: emphasizing the role of high-dose therapy. Clin Lymphoma 2001;2:21-28.
3. Glue P, Fang JW, Rouzier-Panis R. Pegylated interferon-alpha-2b: pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data. Hepatitis C intervention therapy group. Clin Pharmacol Ther 2002;68:556-567.
4. Peck-Radosavljevic M, Wichlas M, Homoncik-Kraml M, et al. Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha. Gastroenterology 2002;123:141-151.
5. Tosi P, Zamagni E, Cellini C, et al. Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma. Haematologica 2002;87:408-414.